Biotechnology | CDC | COVID-19 | Diagnostics
Quest Diagnostics planned launch for coronavirus disease 2019 (COVID-19) test
On Mar. 5, 2020, Quest Diagnostics announced it will launch a coronavirus (COVID-19) test service. The new test…
LabCorp launched test for Coronavirus (COVID-19)
On Mar. 5, 2020, LabCorp announced that it was making its LabCorp 2019 Novel Coronavirus (COVID-19), NAA test…
OPKO Health introduced Coronavirus disease (COVID-19) test
On Mar. 5, 2020, BioReference Laboratories, an OPKO Health company, announced it was offering a test for the…
Cocrystal Pharma announced plans to advance Coronavirus program
On Mar. 6, 2020, Cocrystal Pharma announced it had initiated its Coronavirus program. Cocrystal previously entered into a…
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
Bayer advanced more sustainable agricultural solutions utilizing new innovative greenhouses in Marana, Arizona
On Mar. 4, 2020, Bayer announced new sustainable agricultural solutions utilizing innovative greenhouses in Marana, Arizona. The Marana…
Vir Biotec and Alnylam expanded collaboration to advance RNAi therapeutics for reatment of Coronavirus Infection
On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…
Biotechnology | CRISPR | Disease | Genomics | Therapeutics
Oregon Health Sciences doctors first to use CRISPR editing for inherited form of blindness
On Mar. 4, 2020, doctors at the Casey Eye Institute at Oregon Health & Science University in Portland…
Luminex provided updates on critical efforts related to novel Coronavirus
On Mar. 4, 2020, Luminex announced they were working on multiple solutions to augment their NxTAG and ARIES…
University of Washington Medicine deployed new test for coronavirus
On Mar. 4, 2020, the UW Medicine Clinical Virology Lab announced it had received U.S. Food and Drug…
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
Heat Biologics launched program to develop vaccine to protect against COVID-19 coronavirus
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
BioReference Laboratories and State of New Jersey provided testing for Coronavirus 2019
On Mar. 20, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the State of New…
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
Gilead acquired Forty Seven for $49 billion in cash
On Mar. 2, 2020, Gilead Sciences announced it had acquired Forty Seven for $95.50 per share in cash…
Biotechnology | COVID-19 | FDA | Therapeutics
Mateon updated Rapid Antiviral Response Program Initially targeting COVID-19
On Mar. 2, 2020, Mateon Therapeutics reported the company had been evaluating its therapeutic and AI platforms to…
Ophirex received Wellcome Trust award to advance clinical development of novel snakebite treatment
On Mar. 2, 2020, Ophirex announced that it had received a $2.5 million award from the Wellcome Trustďľ’s…
Innovation Pharma provided scientific rationale and clinical development perspectives for Brilacidin as potential Coronavirus treatment
On Mar. 2, 2020, Innovation Pharma provided the scientific rationale and clinical development perspectives for Brilacidin, the Company’s…
COVID-19 | Diagnostics | Therapeutics | WHO
UN released $15 million to help vulnerable countries battle the spread of the coronavirus
On Mar. 1, 2020, the United Nations Humanitarian Chief Mark Lowcock released US$15 million from the Central Emergency…
University of Washington Medicine received FDA permission to conduct coronavirus tests
On Feb. 29, 2020, the University of Washington (UW) Medicine Clinical Virology Lab announced it had received U.S….
The FDA approved a generic version of Daraprim for the treatment of toxoplasmosis
On Feb. 28, 2020, the FDA approved an application for the first generic of Daraprim (pyrimethamine) tablets for…
Mutations can reveal how the coronavirus moves, but they’re easy to overinterpret
On Feb. 28, 2020, immediately after Christian Drosten published a genetic sequence of the novel coronavirus online, he…
CDC | COVID-19 | Diagnostics | NIH | Therapeutics | Vaccine
COVID-19 a reminder of the challenge of emerging infectious diseases
On Feb. 28, 2020, commentary appeared in The New England Journal of Medicine that discussed the emergence and…
Altimmune Completed First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine
On Feb. 28, 2020, Altimmune announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology…
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
On Feb. 27, 2020, a consortium of philanthropic, non-profit and private sector organisations launched a collaboration that aims…
Innovation Pharma shipped Brilacidin to U.S. Regional Biocontainment Laboratory for research against Coronavirus COVID-19
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
NIH announced $1 million prize competition to target global disease diagnostics
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
Georgia Tech and Shriners Hospitals for Children announced new collaborative research affiliation
On Feb. 26, 2020, Georgia Institute of Technology and Shriners Hospitals for Children announced a collaborative research affiliation…
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
New images of novel Coronavirus SARS-CoV-2 made available
On Feb. 26, 2020, the National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories (NIAID-RML) announced it…